Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease

Br J Haematol. 2021 Oct;195(2):158-159. doi: 10.1111/bjh.17702. Epub 2021 Aug 2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / therapeutic use
  • Humans
  • Hydroxyurea* / therapeutic use
  • Neuroprotection

Substances

  • Antisickling Agents
  • Hydroxyurea